John Ashburner Selected Research

Dopamine (Intropin)

1/2017

l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Ashburner Research Topics

Disease

5	Parkinson Disease (Parkinson's Disease) 01/2018 - 03/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2018 - 01/2013
1	Aphasia (Dysphasia) 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Tremor (Tremors) 01/2018
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Atrophy 01/2018
1	Essential Tremor (Essential Tremors) 01/2018
1	Cluster Headache (Cluster Headaches) 11/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 07/2010
1	Neurodevelopmental Disorders 11/2003
1	Pure Autonomic Failure 04/2003

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
1	IronIBA 01/2018
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	N-trifluoroacetyladriamycinol (AD 92)IBA 07/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2003

Therapy/Procedure

4	Deep Brain Stimulation 01/2018 - 03/2012
1	Therapeutics 11/2020
1	Radiotherapy 01/2019
1	Denervation 04/2003